MedPath

Prospective Study on a Plasma Metabolome Multimarker Panel MxP® PancreasScore for the Diagnosis of Pancreatic Cancer in Cohorts at Risk

Conditions
PANKREASRAUMFORDERUNG
Diabetes mellitus
E10-E14
C25
Malignant neoplasm of pancreas
Registration Number
DRKS00010866
Lead Sponsor
MU Klinikum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
1435
Inclusion Criteria

Patients with solid pancreatic mass lesion on imaging (abdominal CT), which requires further diagnostics (including patients with newly diagnosed diabetes (DM), familial PDAC and chronic pancreatitis (CP)
OR
diagnosis of diabetes over the age of 50 years

Exclusion Criteria

inability to give informed consent,
pregnant or breastfeeding women,
conditions precluding surgery, biopsy or clinical follow-up justify exclusion from the study.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath